Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Rebamipide

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 129Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 8Mucosta

    02 8Mucosta Ophthalmic Suspension

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Mucosta Ophthalmic Suspension

    Rebamipide

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Mucosta Ophthalmic Suspension

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Otsuka

    Rebamipide

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2020 Revenue in Millions : 49

    2019 Revenue in Millions : 50

    Growth (%) : -2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Mucosta

    Rebamipide

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Mucosta

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Otsuka

    Rebamipide

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2020 Revenue in Millions : 72

    2019 Revenue in Millions : 82

    Growth (%) : -12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Mucosta Ophthalmic Suspension

    Rebamipide

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Mucosta Ophthalmic Suspension

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Otsuka

    Rebamipide

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2021 Revenue in Millions : 46

    2020 Revenue in Millions : 47

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Mucosta

    Rebamipide

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Mucosta

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Otsuka

    Rebamipide

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2021 Revenue in Millions : 72

    2020 Revenue in Millions : 69

    Growth (%) : 12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Mucosta Ophthalmic Suspension

    Rebamipide

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Mucosta Ophthalmic Suspension

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Otsuka

    Rebamipide

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2022 Revenue in Millions : 42

    2021 Revenue in Millions : 46

    Growth (%) : -9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Mucosta

    Rebamipide

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Mucosta

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Otsuka

    Rebamipide

    Main Therapeutic Indication : Gastrointestinal Diseases

    Currency : USD

    2022 Revenue in Millions : 78

    2021 Revenue in Millions : 72

    Growth (%) : 9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Mucosta Ophthalmic Suspension

    Rebamipide

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Mucosta Ophthalmic Suspension

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Otsuka

    Rebamipide

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2023 Revenue in Millions : 29

    2022 Revenue in Millions : 42

    Growth (%) : -20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Mucosta

    Rebamipide

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Mucosta

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Otsuka

    Rebamipide

    Main Therapeutic Indication : Gastrointestinal Diseases

    Currency : USD

    2023 Revenue in Millions : 71

    2022 Revenue in Millions : 78

    Growth (%) : 3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Mucosta

    Rebamipide

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Mucosta

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Otsuka

    Rebamipide

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2016 Revenue in Millions : 117

    2015 Revenue in Millions : 144

    Growth (%) : -19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Mucosta Ophthalmic Suspension

    Rebamipide

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Mucosta Ophthalmic Suspension

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Otsuka

    Rebamipide

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2016 Revenue in Millions : 45

    2015 Revenue in Millions : 45

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF